Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review
about
Potential use of COX-2-aromatase inhibitor combinations in breast cancerColorectal cancer after start of nonsteroidal anti-inflammatory drug useLow-dose aspirin in the primary prevention of rheumatoid arthritis: the Women's Health Study.Concept of chemoprevention in colorectal cancer.Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps.Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized studyChemoprevention of colorectal neoplasia.Volume of blood loss during surgery for colon cancer is a risk determinant for future small bowel obstruction caused by recurrence--a population-based epidemiological study.Inflammatory potential of the diet and mortality in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain).Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease[6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin.Changes in vasoconstrictor and vasodilator neurotransmitters in nerves supplying arterioles in developing colorectal polyps.
P2860
Q28187414-565BA3AF-1F31-4F69-A172-ACC484D74CB7Q28218715-2C148F0E-2527-4296-A0D5-D374CCBA4626Q34343159-725B6255-8319-4351-BCDA-C52886968AE4Q34390842-3CA22981-F59A-4A22-808E-2FFD97261A13Q34432899-3455EB1A-EE23-43B1-AF1B-57F0BF98AD6BQ35473697-DE885042-57B0-4A1F-B2A0-1C95BC96DE86Q35870424-D5B1A2F5-99B5-4E5E-B491-9F884D72D9DDQ36290438-D98AFDE4-05C4-446D-AEAE-86F30C73BDF1Q36402212-030D5284-E897-41C4-9686-DA4A573269EDQ37092129-AD409F4B-B81D-4BC9-B425-AC33A0349D75Q37101384-7488A7E0-0650-48AD-8E32-E92A7133E296Q38674336-619286AA-D4F0-43E7-9692-4C0C5D07432BQ38992805-A69A8B58-BE6C-492E-A5C0-3DF9CA9C48C0Q40360991-4BAD1F2D-C400-42B8-B737-351B3B03BE69Q41404998-E38C700E-310F-4E23-80A3-20D08A92F5DEQ41891210-C9F615D3-D63D-430D-A7AF-0FE93FE3AB34Q45286157-B28771A8-8835-4C92-A616-D27AB70A219DQ46934352-9FF34FC8-2214-45D7-B12F-74A7F0897E65
P2860
Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@ast
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@en
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@nl
type
label
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@ast
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@en
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@nl
prefLabel
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@ast
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@en
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@nl
P1476
Nonsteroidal anti-inflammatory ...... nd cancer: a systematic review
@en
P2093
P2888
P304
P356
10.1007/S10350-003-0111-9
P407
P577
2004-05-01T00:00:00Z
P6179
1029250369